Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Epigenomics AG | ECX | Jan 10, 2025 | 1.30 | -7.14 |
Epiroc A | 3AD1 | Jan 10, 2025 | 16.78 | -0.03 |
EPIROC AB UNSP.ADR/1 | 3ADA | Jan 10, 2025 | 16.20 | 0.00 |
Epiroc B | 3AD2 | Jan 10, 2025 | 14.91 | +1.57 |
Episurf Medical B | 16E | Jan 10, 2025 | 0.00 | +20.00 |
ePlus inc. | MLE | Jan 10, 2025 | 73.00 | 0.00 |
EPR Properties | E2H | Jan 10, 2025 | 44.01 | +1.36 |
EPRCOMUNICAZIONE S.P.A. | J3P | Jan 10, 2025 | 1.05 | 0.00 |
EPTI AB AK | G7H0 | Jan 10, 2025 | 3.38 | -5.59 |
Epwin Group Plc | 2E3 | Jan 10, 2025 | 1.11 | +0.91 |
EQB INC. | V22 | Jan 10, 2025 | 71.50 | +2.14 |
EQL Pharma | 7JK | Jan 10, 2025 | 6.76 | -2.59 |
EQT | 6EQ | Jan 10, 2025 | 28.16 | +1.15 |
EQT Corporation | EQ6 | Jan 10, 2025 | 48.59 | +2.77 |
Eqtec | KEU | Jan 10, 2025 | 0.01 | -29.41 |
Equals Group Plc | 2FX | Jan 10, 2025 | 1.54 | 0.00 |
Equatorial Resources Limited | PBU | Jan 10, 2025 | 0.07 | 0.00 |
Equifax, Inc. | EFX | Jan 10, 2025 | 238.00 | -0.83 |
Equillium, Inc. | 0FY | Jan 10, 2025 | 0.68 | +3.04 |
Equinix, Inc. | EQN2 | Jan 10, 2025 | 915.80 | +0.04 |
Equinor | DNQ | Jan 10, 2025 | 24.90 | +0.75 |
Equinor ASA | DNQA | Jan 10, 2025 | 24.50 | +0.41 |
Equinox Gold Corp | 1LRC | Jan 10, 2025 | 5.90 | +5.43 |
EQUIPMAKE HLDGS LS -,0001 | U8O | Jan 10, 2025 | 0.01 | 0.00 |
Equitable Holdings Inc | AXJ | Jan 10, 2025 | 46.80 | 0.00 |
Equity Bancshares, Inc. - Class A | 44X | Jan 10, 2025 | 39.40 | +0.51 |
Equity Commonwealth | HP5A | Jan 10, 2025 | 1.59 | -7.56 |
Equity Lifestyle Properties, Inc. | MHV | Jan 10, 2025 | 62.50 | -1.57 |
EQUITY METALS CORP. | EGSD | Jan 10, 2025 | 0.11 | +10.78 |
Equity Residential | EQR | Jan 10, 2025 | 65.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.